PPT-Cannabis Use Disorder Presentation provided by Selene Etches MD, FRCPC

IWK Health Centre Halifax Nova Scotia CSAMSCAM Fundamentals DISCLOSURE No conflict of interest to declare No pharmaceutical industry support No support from cannabis producers Fundamentals Cannabis Dependence. Cannabis contains a number of active substances like dronabinol THC and cannabidiol CBD THC is mainly responsible for the e64256ects of cannabis but others like CBD may also in64258uence the e64256ectiveness of the drug The chemical composition of Dr. Bareket Schiff Keren. Some history. GLOBAL. AND. LOCAL. Gan. -. zi. -gun-nu. – the drug that takes away the mind. Azallu. . – hand of ghost, poison of all limbs. (neurological diseases?). YOUR NAME. Chapter Chairwoman. #. womengrow. CONNECT. EDUCATE. EMPOWER. Women Will Lead Cannabis Purchasing. Women make more than 80% of healthcare purchasing . decisions. Women account for 93% OTC pharmaceutical . Talking to your doctor, Safety and Update on Clinical Trials. Lubov. . Romantseva. , MD. Child Neurology and Epilepsy. Rush University Medical Center. Nov 12, 2016. Disclosures. I have no financial interest in any pharmaceutical company mentioned in this presentation. 11/. . 12. . /. . 16. Bob Morgan. Illinois Medical Cannabis Pilot Program Act. 2. Four . year pilot program beginning January 1, 2014 entitled the . “Illinois Compassionate Use of Medical . Cannabis Pilot Program . September 2016. Implementation Timeline. Office of Compassionate Use Established. : July 1, 2014. Florida Administrative Code Chapter 64-4 Promulgated, Final Rule Upheld: . May 28, 2015. Dispensing Organization Applications Accepted: . Professor Jennifer H. Martin . MBChB. , FRACP, PhD. Chair, Clinical Pharmacology. Uni. of Newcastle, Australia. Overview. Need for evidence . Where there is evidence. Challenges of cannabis research . Presented by: Candice Beathard, PhD. December 15, 2015 . Background: History of Cannabis as Medicine . Dates back to 2727B.C. in China. 1. In U.S…. 1850: cannabis tinctures patented. 2. . 1963: chemical structure of cannabis identified. Presented by: Candice Beathard, PhD. December 15, 2015 . Background. 23 States and D.C. have enacted medical cannabis programs. 1. . 1. Marijuana Policy Project, 2015. . Background. State programs specify list of qualifying conditions. drug control . system and its effects on science. Tom Blickman– TNI. tblick@tni.org. The Rise and Decline of Cannabis Prohibition. The . History of Cannabis in the UN Drug Control System and Options For Reform. Jordan Tishler, MD. InhaleMD. MYTH: . Women aren’t interested. U.S. Women are sexually active. 65-70% - age 18-50 . - . Decreasing to 20-40% by age 90. Female Sexual Dysfunction = 40%. Male sexual dysfunction Is more . What are the effects of the current cannabis policy? . How is cannabis policy changing in other states?. What technical elements need to be addressed? . What goals should Minnesota have for legalizing adult-use cannabis?. Dra. Leticia Cuñetti. June 2018. . I declare that I have no conflicts of interest to make this presentation.. . . Dra. Leticia Cuñetti . Delmonte. June 2018. Chronic pain is a major therapeutic problem in patients with kidney transplant due to the nephrotoxicity of NSAIDs. amongst . low-SES users and the arrival of CBD . on . the retail market . . . Dr Frances . Thirlway. , University of York, Sociology Department.  . .  . EMERGING FINDINGS.  . Cannabis was readily available and used alongside .